Logo image of EXRO.CA

EXRO TECHNOLOGIES INC (EXRO.CA) Stock Fundamental Analysis

TSX:EXRO - Toronto Stock Exchange - CA30222R1091 - Common Stock - Currency: CAD

0.08  -0.01 (-15.79%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EXRO. EXRO was compared to 14 industry peers in the Electrical Equipment industry. EXRO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EXRO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EXRO had negative earnings in the past year.
EXRO had a negative operating cash flow in the past year.
EXRO had negative earnings in each of the past 5 years.
In the past 5 years EXRO always reported negative operating cash flow.
EXRO.CA Yearly Net Income VS EBIT VS OCF VS FCFEXRO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

EXRO has a worse Return On Assets (-148.91%) than 61.54% of its industry peers.
EXRO's Return On Equity of -623.68% is on the low side compared to the rest of the industry. EXRO is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
ROA -148.91%
ROE -623.68%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXRO.CA Yearly ROA, ROE, ROICEXRO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EXRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXRO.CA Yearly Profit, Operating, Gross MarginsEXRO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

1

2. Health

2.1 Basic Checks

EXRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
EXRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXRO.CA Yearly Shares OutstandingEXRO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M
EXRO.CA Yearly Total Debt VS Total AssetsEXRO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -4.17, we must say that EXRO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -4.17, EXRO is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
EXRO has a Debt/Equity ratio of 2.22. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.22, EXRO is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Altman-Z -4.17
ROIC/WACCN/A
WACC7.06%
EXRO.CA Yearly LT Debt VS Equity VS FCFEXRO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

2.3 Liquidity

EXRO has a Current Ratio of 1.19. This is a normal value and indicates that EXRO is financially healthy and should not expect problems in meeting its short term obligations.
EXRO has a Current ratio of 1.19. This is in the lower half of the industry: EXRO underperforms 61.54% of its industry peers.
A Quick Ratio of 0.54 indicates that EXRO may have some problems paying its short term obligations.
EXRO's Quick ratio of 0.54 is on the low side compared to the rest of the industry. EXRO is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.54
EXRO.CA Yearly Current Assets VS Current LiabilitesEXRO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

EXRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -148.15%.
Looking at the last year, EXRO shows a very strong growth in Revenue. The Revenue has grown by 161.65%.
EPS 1Y (TTM)-148.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-616.67%
Revenue 1Y (TTM)161.65%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%439.87%

3.2 Future

The Earnings Per Share is expected to grow by 23.81% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 153.05% on average over the next years. This is a very strong growth
EPS Next Y-47.9%
EPS Next 2Y28.28%
EPS Next 3Y23.81%
EPS Next 5YN/A
Revenue Next Year315.36%
Revenue Next 2Y284.72%
Revenue Next 3Y229.13%
Revenue Next 5Y153.05%

3.3 Evolution

EXRO.CA Yearly Revenue VS EstimatesEXRO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
EXRO.CA Yearly EPS VS EstimatesEXRO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXRO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EXRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXRO.CA Price Earnings VS Forward Price EarningsEXRO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EXRO.CA Per share dataEXRO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as EXRO's earnings are expected to grow with 23.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.28%
EPS Next 3Y23.81%

More info and screens

0

5. Dividend

5.1 Amount

EXRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXRO TECHNOLOGIES INC

TSX:EXRO (2/21/2025, 7:00:00 PM)

0.08

-0.01 (-15.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-31 2025-03-31/amc
Inst Owners17.14%
Inst Owner ChangeN/A
Ins Owners12.93%
Ins Owner ChangeN/A
Market Cap43.96M
Analysts76.36
Price Target0.47 (487.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-395.16%
Min EPS beat(2)-796.95%
Max EPS beat(2)6.63%
EPS beat(4)2
Avg EPS beat(4)-214.66%
Min EPS beat(4)-796.95%
Max EPS beat(4)6.63%
EPS beat(8)4
Avg EPS beat(8)-109%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-53.19%
Min Revenue beat(2)-69.33%
Max Revenue beat(2)-37.05%
Revenue beat(4)0
Avg Revenue beat(4)-48.12%
Min Revenue beat(4)-69.33%
Max Revenue beat(4)-37.05%
Revenue beat(8)2
Avg Revenue beat(8)174.61%
Revenue beat(12)4
Avg Revenue beat(12)134.31%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.61%
EPS NQ rev (1m)-6.85%
EPS NQ rev (3m)-212%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)-128.47%
Revenue NQ rev (1m)-1.91%
Revenue NQ rev (3m)-86.91%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)-38.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.55
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.03
BVpS0.08
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -148.91%
ROE -623.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.19%
Cap/Sales 26.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.54
Altman-Z -4.17
F-Score3
WACC7.06%
ROIC/WACCN/A
Cap/Depr(3y)722.65%
Cap/Depr(5y)541.8%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-148.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-616.67%
EPS Next Y-47.9%
EPS Next 2Y28.28%
EPS Next 3Y23.81%
EPS Next 5YN/A
Revenue 1Y (TTM)161.65%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%439.87%
Revenue Next Year315.36%
Revenue Next 2Y284.72%
Revenue Next 3Y229.13%
Revenue Next 5Y153.05%
EBIT growth 1Y-102.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-39.09%
EBIT Next 3Y35.26%
EBIT Next 5Y19.59%
FCF growth 1Y-48.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.8%
OCF growth 3YN/A
OCF growth 5YN/A